Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative endocrine therapy combinations for hormone receptor-positive breast cancer
ACTRN12618000928213Phase 2Recruiting
- Sponsor
- St Vincent's Hospital
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in breast cancer comparing Letrozole alone, Letrozole + progesterone and Tamoxifen + progesterone (3 arms). Primary endpoint: Ki67 suppression. Started Mar 2018; status: recruiting.
02
Drugs
letrozoleprogesteronetamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12618000928213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000928213.